In honor of CHD awareness week, the people of the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome at Mayo Clinic would like to express our gratitude to all of our families that have participated in our research, inquired and helped spread the word. It is because of each and every one of you that better outcomes for people with HLHS will come to fruition. Again, we thank you!
As we work toward our vision of delaying or preventing heart transplant for people with HLHS, the program's overall goal is to initiate clinical trials that bring the latest advances in cell therapy to people with HLHS. Ultimately, we hope this knowledge will transcend HLHS to improve the lives of those affected with other Congenital Heart Defects as well. It is the faces we see every day, much like the beautiful faces in this video, which will continue to drive us to fulfilling our vision and encourage all of us to never stop dreaming about life over the rainbow.
The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is a collaborative network of specialists bonded by the vision of delaying or preventing heart failure for individuals affected by congenital heart defects including HLHS. The specialized team is addressing the various aspects of these defects by using research and clinical strategies ranging from basic science to diagnostic imaging to regenerative therapies.